Status:
COMPLETED
NeoRes Study - Preoperative Chemotherapy in Colorectal Peritoneal Disease Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Lead Sponsor:
Uppsala University
Collaborating Sponsors:
Uppsala University Hospital
Conditions:
Colorectal Cancer Metastatic
Peritoneal Metastases From Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Study Title: Neores Study - Evaluating Systemic Chemotherapy Efficacy in Colorectal Peritoneal Metastases Principal Investigator: Peter Cashin Akademiska sjukhuset / Uppsala universitet Background...
Detailed Description
Neores Study: Evaluating Systemic chemotherapy efficacy in colorectal peritoneal metastases Ansvarig forskare: Peter Cashin Akademiska sjukhuset / Uppsala universitet Research plan Background The e...
Eligibility Criteria
Inclusion
- HIPEC MDK where extensive isolated peritoneal metastases are noted
- Colorectal cancer
- Decision during HIPEC MDT to start systemic conversion chemotherapy
Exclusion
- Appendiceal cancer
- Retroperitoneal lymph node metastases
- Other systemic metastases (e.g. liver, lung, brain, bone etc)
Key Trial Info
Start Date :
March 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 21 2025
Estimated Enrollment :
185 Patients enrolled
Trial Details
Trial ID
NCT06903039
Start Date
March 21 2019
End Date
March 21 2025
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akademiska Sjukhuset (Uppsala University hospital)
Uppsala, Sweden, 75185